iPill Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.29M

  • Investors
  • 8

iPill General Information

Description

Developer of a secure medication dispenser designed to help remove barriers to Suboxone Opioid Use Disorder therapy by offering safe, effective, at-home treatment. The company's device addresses the opioid crisis that predominantly impacts low-income communities by destroying unused medication, controlling dispensing and tracking medication adherence by creating a tamper-proof home dispenser for opioids, enabling healthcare systems to take steps towards addressing unequal prescribing practices and standardizing care.

Contact Information

Website
www.ipill.tech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 17532 Marengo Drive
  • Rowland Heights
  • Los Angeles, CA 91748
  • United States
+1 (626)
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health
Corporate Office
  • 17532 Marengo Drive
  • Rowland Heights
  • Los Angeles, CA 91748
  • United States
+1 (626)

iPill Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iPill Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 13-Oct-2026 $1.29M Completed Generating Revenue
5. Seed Round 03-Apr-2025 Completed Generating Revenue
4. Equity Crowdfunding 22-May-2021 Completed Pre-Clinical Trials
3. Accelerator/Incubator 29-Mar-2021 Completed Pre-Clinical Trials
2. Accelerator/Incubator 14-Nov-2019 $25K $25K Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view iPill’s complete valuation and funding history, request access »

iPill Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 3
Seed 2
Seed 1 3,816,797 $0.000100 8% $0.42 $0.42 1x $0.42 8.69%
Seed 6,384,530 $0.000100 8% $0.55 $0.55 1x $0.55 14.54%
To view iPill’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

iPill Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a secure medication dispenser designed to help remove barriers to Suboxone Opioid Use Disorder therapy by o
Other Devices and Supplies
Los Angeles, CA
9 As of 2025

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

iPill Competitors (1)

One of iPill’s competitors is MedicaSafe, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MedicaSafe Venture Capital-Backed New York, NY
You’re viewing 1 of 1 competitors. Get the full list »

iPill Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

iPill Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fischli Venture Venture Capital Minority
Hunt Companies Real Estate Minority
OCA Ventures Venture Capital Minority
Sixth Borough Capital Management Hedge Fund Minority
Startupbootcamp Holding Accelerator/Incubator Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

iPill FAQs

  • When was iPill founded?

    iPill was founded in 2017.

  • Where is iPill headquartered?

    iPill is headquartered in Los Angeles, CA.

  • What is the size of iPill?

    iPill has 9 total employees.

  • What industry is iPill in?

    iPill’s primary industry is Other Devices and Supplies.

  • Is iPill a private or public company?

    iPill is a Private company.

  • What is the current valuation of iPill?

    The current valuation of iPill is .

  • What is iPill’s current revenue?

    The current revenue for iPill is .

  • How much funding has iPill raised over time?

    iPill has raised $5.91M.

  • Who are iPill’s investors?

    Fischli Venture, Hunt Companies, OCA Ventures, Sixth Borough Capital Management, and Startupbootcamp Holding are 5 of 8 investors who have invested in iPill.

  • Who are iPill’s competitors?

    MedicaSafe is a competitor of iPill.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process